Persistent and transient olfactory deficits in COVID-19 are associated to inflammation and zinc homeostasis.

RNA-seq SARS-CoV-2 inflammation metallothionein miRNA olfactory symptoms zinc homeostasis

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 20 01 2023
accepted: 29 06 2023
medline: 31 7 2023
pubmed: 31 7 2023
entrez: 31 7 2023
Statut: epublish

Résumé

The Coronavirus Disease 2019 (COVID-19) is mainly a respiratory syndrome that can affect multiple organ systems, causing a variety of symptoms. Among the most common and characteristic symptoms are deficits in smell and taste perception, which may last for weeks/months after COVID-19 diagnosis owing to mechanisms that are not fully elucidated. In order to identify the determinants of olfactory symptom persistence, we obtained olfactory mucosa (OM) from 21 subjects, grouped according to clinical criteria: i) with persistent olfactory symptoms; ii) with transient olfactory symptoms; iii) without olfactory symptoms; and iv) non-COVID-19 controls. Cells from the olfactory mucosa were harvested for transcriptome analyses. RNA-Seq assays showed that gene expression levels are altered for a long time after infection. The expression profile of micro RNAs appeared significantly altered after infection, but no relationship with olfactory symptoms was found. On the other hand, patients with persistent olfactory deficits displayed increased levels of expression of genes involved in the inflammatory response and zinc homeostasis, suggesting an association with persistent or transient olfactory deficits in individuals who experienced

Identifiants

pubmed: 37520523
doi: 10.3389/fimmu.2023.1148595
pmc: PMC10380959
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1148595

Informations de copyright

Copyright © 2023 Lupi, Bordin, Sales, Colaianni, Vitiello, Biscontin, Reale, Garzino-Demo, Antonini, Ottaviano, Mucignat, Parolin, Calistri and De Pittà.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Br J Dermatol. 2019 Apr;180(4):869-880
pubmed: 30339739
C R Biol. 2021 Jun 21;344(1):19-25
pubmed: 34213846
Front Immunol. 2019 Aug 27;10:1958
pubmed: 31507592
Biofactors. 2000;12(1-4):65-70
pubmed: 11216508
Int J Mol Sci. 2020 Nov 25;21(23):
pubmed: 33255662
Neurosci Lett. 2021 Mar 23;748:135694
pubmed: 33600902
Consult Pharm. 2016 May;31(5):267-70
pubmed: 27178656
Bioinformatics. 2009 Oct 15;25(20):2685-91
pubmed: 19628505
Int J Mol Sci. 2017 Oct 23;18(10):
pubmed: 29065550
Clin Infect Dis. 2020 Jul 28;71(15):889-890
pubmed: 32215618
Biol Trace Elem Res. 2022 Jul;200(7):3138-3146
pubmed: 34608570
Bull Exp Biol Med. 2018 Mar;164(5):655-657
pubmed: 29577185
Eur J Neurosci. 2004 Apr;19(7):1800-10
pubmed: 15078553
J Nutr Biochem. 2020 Mar;77:108240
pubmed: 31841960
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
Front Immunol. 2020 Jul 10;11:1712
pubmed: 32754164
Lung. 2021 Jun;199(3):237-238
pubmed: 33893845
Int J Infect Dis. 2022 Sep;122:553-558
pubmed: 35724828
iScience. 2020 Dec 18;23(12):101839
pubmed: 33251489
Front Immunol. 2021 Apr 21;12:593473
pubmed: 33968012
Neural Regen Res. 2022 Jul;17(7):1623-1624
pubmed: 34916450
Handb Clin Neurol. 2019;164:67-78
pubmed: 31604564
PLoS One. 2022 Jun 30;17(6):e0270024
pubmed: 35771751
Life (Basel). 2021 Feb 26;11(3):
pubmed: 33652690
Nat Rev Immunol. 2013 Mar;13(3):159-75
pubmed: 23435331
Front Immunol. 2015 Jan 29;6:19
pubmed: 25688245
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Chem Senses. 2020 Jun 17;:
pubmed: 32556089
Front Immunol. 2021 Feb 18;12:613422
pubmed: 33679753
J Cell Biol. 2007 May 21;177(4):637-45
pubmed: 17502426
Clin Exp Allergy. 2006 Nov;36(11):1357-66
pubmed: 17083345
J Neurosci. 2000 Oct 15;20(20):7691-7
pubmed: 11027230
Nat Neurosci. 2020 Mar;23(3):323-326
pubmed: 32066986
Pathog Dis. 2019 Dec 1;77(9):
pubmed: 32065221
Med. 2021 Jan 15;2(1):99-112.e7
pubmed: 32838362
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72
pubmed: 12011421
Protein Cell. 2016 Feb;7(2):100-13
pubmed: 26399619
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Laryngoscope. 2020 Jul;130(7):1787
pubmed: 32237238
F1000Res. 2016 Jun 20;5:1438
pubmed: 27508061
F1000Res. 2015 Dec 30;4:1521
pubmed: 26925227
Nutrients. 2020 Aug 07;12(8):
pubmed: 32784601
Chem Senses. 1997 Feb;22(1):39-52
pubmed: 9056084
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Cell. 2022 Mar 17;185(6):1052-1064.e12
pubmed: 35180380
Front Neural Circuits. 2022 Apr 25;16:862005
pubmed: 35547642
J Infect Dis. 2020 Aug 4;222(5):722-725
pubmed: 32559285
Neuroscientist. 2021 Dec;27(6):582-603
pubmed: 32914699
RNA. 2007 Jan;13(1):151-9
pubmed: 17105992
Arthritis Rheumatol. 2023 Mar 2;:
pubmed: 36862398
Int J Infect Dis. 2013 Feb;17(2):e76-83
pubmed: 23069683
Front Immunol. 2022 Jun 30;13:906551
pubmed: 35844578
Endocr Metab Immune Disord Drug Targets. 2009 Jun;9(2):132-44
pubmed: 19519463
Nat Commun. 2020 Nov 17;11(1):5829
pubmed: 33203887
Front Immunol. 2022 Jun 10;13:912336
pubmed: 35757770
EMBO Mol Med. 2020 Jul 7;12(7):e12421
pubmed: 32428990
Virus Res. 2019 Jan 15;260:1-6
pubmed: 30412711
Cell Mol Life Sci. 2012 Nov;69(21):3533-41
pubmed: 22971773
Nat Genet. 2022 Feb;54(2):121-124
pubmed: 35039640
Brain Behav Immun. 2020 Oct;89:579-586
pubmed: 32629042
Cell Death Dis. 2019 Sep 9;10(9):646
pubmed: 31501413
Clin Microbiol Infect. 2020 Oct;26(10):1426-1427
pubmed: 32447049
Cell Mol Life Sci. 2002 Apr;59(4):627-47
pubmed: 12022471
Sci Adv. 2020 Jul 31;6(31):
pubmed: 32937591
Lancet Neurol. 2021 Sep;20(9):693-695
pubmed: 34339627
Laryngoscope Investig Otolaryngol. 2020 Dec 25;6(1):21-24
pubmed: 33614925
Clin Nutr Open Sci. 2022 Aug;44:144-154
pubmed: 35783349
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Trends Mol Med. 2022 Sep;28(9):781-794
pubmed: 35810128
Nat Biotechnol. 2014 Sep;32(9):896-902
pubmed: 25150836
Sci Transl Med. 2021 Jun 2;13(596):
pubmed: 33941622
Science. 2020 Jul 10;369(6500):125-126
pubmed: 32646977

Auteurs

Lorenzo Lupi (L)

Department of Biology, University of Padova, Padova, Italy.
Department of Molecular Medicine, University of Padova, Padova, Italy.

Anna Bordin (A)

Department of Neurosciences, Otolaryngology Section, University of Padova, Padova, Italy.

Gabriele Sales (G)

Department of Biology, University of Padova, Padova, Italy.

Davide Colaianni (D)

Department of Biology, University of Padova, Padova, Italy.

Adriana Vitiello (A)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Alberto Biscontin (A)

Department of Biology, University of Padova, Padova, Italy.

Alberto Reale (A)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Alfredo Garzino-Demo (A)

Department of Molecular Medicine, University of Padova, Padova, Italy.
Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, United States.

Angelo Antonini (A)

Parkinson and Movement Disorders Unit, Department of Neurosciences, University of Padova, Padova, Italy.
Department of Neurosciences, University of Padova, Padova, Italy.

Giancarlo Ottaviano (G)

Department of Neurosciences, Otolaryngology Section, University of Padova, Padova, Italy.

Carla Mucignat (C)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Cristina Parolin (C)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Arianna Calistri (A)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Cristiano De Pittà (C)

Department of Biology, University of Padova, Padova, Italy.

Classifications MeSH